Although SAMD13 is highly expressed in various types of cancer, it was significantly associated with shorter OS, DSS, DFI, and PFI in patients with HCC, even poorly differentiated HCC cell lines which tend to be more aggressive and higher grade. Here, SAMD13 is linked to hepatocellular carcinoma.